Drive the launch of innovative therapies by collaborating with healthcare professionals in a dynamic, community-focused environment, influencing the skeletal dysplasia landscape and delivering impactful results for families.

Take ownership of a key territory by driving acumen, collaboration, and community engagement for a first-in-class achondroplasia therapy, while managing provider relationships and achieving commercial success.

Lead the charge in commercial analytics and insights, driving strategy for in-line rare disease therapeutics. Collaborate with cross-functional teams to enhance reporting, forecast models, and competitive intelligence for impactful decision-making.

Shape the future of biopharmaceutical quality assurance by overseeing Drug Product CMO operations. Ensure compliance with cGMP standards, manage batch records, and lead quality reviews to foster a culture of excellence and timely issue resolution.

Empower families and providers in skeletal dysplasia by driving the launch of innovative therapies, cultivating key relationships, and advancing your expertise in a dynamic market focused on patient-centered solutions.